Thomas Ligus, MD in Eagle River, AK - Internal Medicine

Thomas Ligus, MD is a Internal Medicine physician based in Eagle River, Alaska. Thomas Ligus is licensed to practice in Alaska (license number 2015) and his current practice location is 11432 Business Blvd, Eagle River, Alaska. He can be reached at his office (for appointments etc.) via phone at (907) 694-1300.

NPI number for Thomas Ligus is 1649340126 and his current mailing address is 200 W 34th Ave, #251, Anchorage, Alaska. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1649340126.

Contact Information

	Thomas Ligus, MD
	11432 Business Blvd, Eagle River, AK 99577-7720
	(907) 694-1300
	(907) 694-1315

Physician's Profile

Full Name	Thomas Ligus
Gender	Male
Speciality	Internal Medicine
Location	11432 Business Blvd, Eagle River, Alaska
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1649340126
Provider Enumeration Date: 11/09/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Thomas Ligus such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1649340126	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	2015 (Alaska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Thomas Ligus is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Thomas Ligus, MD 200 W 34th Ave, #251, Anchorage, AK 99503-3969 Ph: (907) 694-1300	Thomas Ligus, MD 11432 Business Blvd, Eagle River, AK 99577-7720 Ph: (907) 694-1300

News Archive

Researchers use simple tactics to reduce unnecessary blood tests, health care spending

Researchers at Johns Hopkins Bayview Medical Center used two relatively simple tactics to significantly reduce the number of unnecessary blood tests to assess symptoms of heart attack and chest pain and to achieve a large decrease in patient charges.

Endocrine Society publishes Clinical Practice Guideline for treatment of rare adrenal tumors

The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of two types of rare adrenal tumors - pheochromocytomas and paragangliomas - that can raise the risk of cardiovascular disease and even death if left untreated.

TomoTherapy signs purchasing agreement with GNYHA Services

TomoTherapy Incorporated, maker of the TomoTherapy® treatment system for advanced, CT-guided radiation therapy, announced today that it has signed an equipment supply group purchasing agreement with GNYHA Services, Inc. Pursuant to this agreement, TomoTherapy technology will be made available at contracted rates to more than 220 member hospitals in New York, New Jersey, Pennsylvania and Puerto Rico.

NYSE Amex grants PharmAthene extension to demonstrate listing compliance

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that based on information provided by PharmAthene in its compliance plan, and discussions with Exchange staff, the NYSE Amex LLC has determined that the Company made a reasonable demonstration of its ability to regain compliance with the NYSE Amex listing requirements and granted PharmAthene an extension until January 26, 2012 to demonstrate its compliance.

Thomas Ligus, MD - Internal Medicine in Eagle River, AK